AVTE logo

Aerovate Therapeutics, Inc. Common Stock


AVTE: Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe.


Show AVTE Financials

Consumer Interest
SEC Filings

Recent trades of AVTE by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by AVTE's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of AVTE in WallStreetBets Daily Discussion


Recent insights relating to AVTE

CNBC Recommendations

Recent picks made for AVTE stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AVTE

Corporate Flights

Flights by private jets registered to AVTE